Predictors and Outcomes of Subclinical Inflammation in Pediatric FMF

Overview

This study investigates the prevalence and risk factors of subclinical inflammation in pediatric patients with Familial Mediterranean Fever (FMF). It highlights the significance of persistent inflammatory markers in the absence of clinical symptoms and their potential long-term complications.

Background

Familial Mediterranean Fever (FMF) is a prevalent autoinflammatory condition primarily affecting individuals of Mediterranean descent. Subclinical inflammation in FMF can lead to serious complications, including anemia, growth retardation, and amyloidosis, particularly in patients resistant to standard treatments like colchicine. Understanding the predictors of subclinical inflammation is crucial for optimizing management strategies and improving patient outcomes.

Data Highlights

No numerical data available in the source material.

Key Findings

• Subclinical inflammation persists in a subset of pediatric FMF patients despite the absence of overt clinical symptoms.
• Elevated inflammatory markers such as CRP and ESR were noted during attack-free periods.
• Genetic factors, particularly high-risk MEFV mutations, correlate with increased subclinical inflammation.
• Colchicine resistance is associated with a higher likelihood of persistent inflammation.
• Subclinical inflammation can contribute to long-term complications, including AA amyloidosis.

Clinical Implications

Clinicians should monitor inflammatory markers in pediatric FMF patients even during asymptomatic periods to identify subclinical inflammation. Personalized treatment strategies, including the consideration of IL-1 inhibitors for colchicine-resistant patients, may be necessary to mitigate long-term complications.

Conclusion

The study underscores the importance of recognizing and addressing subclinical inflammation in pediatric FMF to prevent serious health complications. Ongoing monitoring and tailored treatment approaches are essential for optimal patient management.

References

1. Subclinical inflammation in pediatric familial Mediterranean fever: predictors and follow-up results of a retrospective single-center cohort study, Clinical Rheumatology, 2026 -- Title
2. Differentiation of Familial Mediterranean Fever Patients During Attack and Remission Phases Using miR-451a and IL18: A Prospective Cross-Sectional Analysis, Clinical Rheumatology, 2025 -- Title
3. Inflammatory Bowel Disease Associated with Pediatric Rheumatological Disorders, Clinical Rheumatology, 2025 -- Title
4. Characterization of Polyunsaturated Fatty Acids in Juvenile Idiopathic Arthritis and Their Relationship with Disease Activity, Clinical Rheumatology, 2017 -- Title
5. Recommendations Management | EULAR, EULAR, 2024 -- Title
6. Clinical Rheumatology — Comprehensive Evaluation of Juvenile Sjögren's Disease
7. Recommendations Management | EULAR
8. Subclinical inflammation in pediatric familial Mediterranean fever: predictors and follow-up results of a retrospective single-center cohort study | Clinical Rheumatology | Springer Nature Link